文献速递鼻科

单克隆抗体对慢性鼻窦炎伴鼻息肉所致嗅觉障碍的疗效:系统综述与荟萃分析

Effect of monoclonal antibodies on olfactory dysfunction caused by chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis.
PubMed 文献 · Int Forum Allergy Rhinol · 2020-05-29

该系统综述与荟萃分析检索多个数据库及试验注册库,最终纳入7项试验共957例慢性鼻窦炎伴鼻息肉患者,评估单克隆抗体对嗅觉障碍的影响。7项研究中有6项显示生物制剂治疗较安慰剂可改善嗅觉障碍,且生物制剂总体安全耐受,未报告嗅觉恶化或丧失病例。

要点

  • 7项试验中6项显示生物制剂较安慰剂改善CRSwNP相关嗅觉障碍。
  • 生物制剂总体安全耐受,未报告嗅觉恶化或嗅觉丧失病例。
  • 嗅觉改善的可持续性及治疗时长尚需进一步研究确定。

核心结论

  • 这是首个针对单克隆抗体治疗CRSwNP患者嗅觉功能临床结局的荟萃分析。
  • 生物制剂对CRSwNP患者嗅觉功能有积极影响,但需进一步研究确定结果可持续性和治疗时长。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、ScienceDirect、Cochrane Library电子数据库及多个试验注册库,并辅以广泛手工检索。
  • 最终纳入7项试验,共957例患者。

主要发现

  • 7项研究中有6项显示,与安慰剂相比,生物制剂治疗可改善嗅觉障碍。
  • 这些生物制剂总体被认为安全且耐受良好。
  • 未报告嗅觉恶化或嗅觉丧失的病例。

临床怎么用

  • 对于CRSwNP相关嗅觉障碍患者,生物制剂治疗可能改善嗅觉功能,且未报告嗅觉恶化或丧失。
  • 嗅觉改善的可持续性及治疗时长尚不明确,临床决策时需考虑进一步研究需求。

局限性

  • 嗅觉功能改善结果的可持续性和治疗时长尚需进一步研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Olfactory dysfunction is a common complaint in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The purpose of this article is to critically review all published literature regarding the impact of monoclonal antibodies on CRSwNP-related olfactory dysfunction. METHODS: An electronic literature search was performed in MEDLINE, ScienceDirect, the Cochrane Library electronic databases, and multiple trial registries, followed by extensive hand-searching for the retrieval of relevant studies. RESULTS: Seven trials with a total of 957 patients were eventually identified and systematically reviewed. Six of 7 studies showed that biologic therapy can improve olfactory dysfunction when compared with placebo. Overall, these biologic agents were considered safe and well-tolerated. No cases of olfactory deterioration or olfactory loss were reported. CONCLUSION: This is the first meta-analysis presenting clinical outcomes with regard to olfactory function in CRSwNP patients who had been treated with monoclonal antibodies. The positive effect of biologic treatment on the olfactory function of these patients requires further study so that the sustainability of results and duration of treatment can be determined.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Tsetsos N, Markou K, Konstantinidis I, et al. Effect of monoclonal antibodies on olfactory dysfunction caused by chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2020. PMID: 32250544. doi:10.1002/alr.22576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。